SW
ABBV icon

SVB Wealth’s AbbVie ABBV Stock Holding History

SVB Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Sell
55,432
-2,857
-5% -$615K 0.88% 25
2026
Q1 		$12.7M Sell
58,289
-10,374
-15% -$2.3M 0.84% 24
2025
Q4 		$15.7M Sell
68,663
-25,194
-27% -$5.74M 0.93% 23
2025
Q3 		$21.7M Sell
93,857
-8,492
-8% -$1.73M 1.17% 18
2025
Q2 		$19M Sell
102,349
-113,330
-53% -$21.1M 1.02% 21
2025
Q1 		$45.2M Sell
215,679
-41,853
-16% -$8.14M 1.86% 6
2024
Q4 		$45.8M Buy
+257,532
New +$47.3M 0.86% 15
2024
Q3 		– Sell
-271,884
Closed -$46.6M – 21
2024
Q2 		$46.6M Sell
271,884
-9,336
-3% -$1.55M 1.15% 12
2024
Q1 		$51.2M Sell
281,220
-11,578
-4% -$2M 1.14% 14
2023
Q4 		$45.4M Sell
292,798
-31,013
-10% -$4.52M 1.1% 12
2023
Q3 		$48.3M Sell
323,811
-11,195
-3% -$1.64M 1.06% 14
2023
Q2 		$45.1M Sell
335,006
-83,988
-20% -$12.3M 0.82% 21
2023
Q1 		$66.8M Sell
418,994
-35,879
-8% -$5.49M 0.93% 17
2022
Q4 		$73.5M Sell
454,873
-2,134
-0.5% -$327K 0.99% 16
2022
Q3 		$61.3M Buy
457,007
+8,586
+2% +$1.23M 0.9% 17
2022
Q2 		$68.7M Buy
448,421
+1,008
+0.2% +$154K 1.06% 15
2022
Q1 		$72.5M Sell
447,413
-21,294
-5% -$3.09M 0.97% 15
2021
Q4 		$63.5M Buy
468,707
+6,939
+2% +$820K 1.04% 15
2021
Q3 		$49.8M Sell
461,768
-7,022
-1% -$802K 0.64% 22
2021
Q2 		$52.8M Sell
468,790
-1,830
-0.4% -$206K 0.67% 21
2021
Q1 		$50.9M Buy
470,620
+7,549
+2% +$807K 0.71% 19
2020
Q4 		$49.6M Sell
463,071
-903
-0.2% -$86.8K 0.73% 20
2020
Q3 		$40.6M Sell
463,974
-23,469
-5% -$2.21M 0.67% 22
2020
Q2 		$47.9M Buy
487,443
+46,943
+11% +$4.13M 0.89% 18
2020
Q1 		$33.6M Buy
440,500
+12,539
+3% +$1.07M 0.81% 21
2019
Q4 		$37.9M Buy
427,961
+2,650
+0.6% +$220K 0.69% 23
2019
Q3 		$32.2M Sell
425,311
-15,957
-4% -$1.09M 0.64% 26
2019
Q2 		$32.1M Sell
441,268
-2,735
-0.6% -$215K 1.08% 18
2019
Q1 		$35.8M Buy
444,003
+19,841
+5% +$1.62M 1.41% 17
2018
Q4 		$39.1M Buy
424,162
+772
+0.2% +$67.9K 1.67% 12
2018
Q3 		$40M Buy
423,390
+1,191
+0.3% +$113K 1.42% 12
2018
Q2 		$39.1M Sell
422,199
-4,818
-1% -$471K 1.5% 9
2018
Q1 		$40.4M Sell
427,017
-8,679
-2% -$953K 1.55% 7
2017
Q4 		$42.1M Sell
435,696
-6,644
-2% -$626K 1.59% 6
2017
Q3 		$39.3M Sell
442,340
-13,540
-3% -$1.03M 1.51% 9
2017
Q2 		$33.1M Sell
455,880
-484
-0.1% -$32.5K 1.3% 12
2017
Q1 		$29.7M Sell
456,364
-15,298
-3% -$962K 1.18% 18
2016
Q4 		$29.5M Sell
471,662
-8,168
-2% -$499K 1.22% 16
2016
Q3 		$30.3M Buy
479,830
+18,420
+4% +$1.19M 1.23% 14
2016
Q2 		$28.6M Sell
461,410
-10,516
-2% -$641K 1.17% 17
2016
Q1 		$27M Buy
471,926
+11,510
+2% +$642K 1.1% 20
2015
Q4 		$27.3M Sell
460,416
-91,144
-17% -$5.25M 1.08% 20
2015
Q3 		$30M Buy
551,560
+66,871
+14% +$4.35M 1.16% 16
2015
Q2 		$32.6M Buy
484,689
+25,771
+6% +$1.68M 1.08% 19
2015
Q1 		$26.9M Buy
458,918
+50,395
+12% +$3.04M 0.87% 31
2014
Q4 		$26.7M Buy
+408,523
New +$25.8M 0.86% 29

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SVB Wealth's ABBV Position: Q2 2026 in Review

SVB Wealth reduced its AbbVie (ABBV) stake by 4.9% in Q2 2026, selling an estimated $615K and leaving 55,432 shares worth $13.9M. The position accounts for 0.88% of the portfolio, ranked #25.

SVB Wealth first reported a position in ABBV in Q4 2014 and has held it in 46 quarters since. The position peaked at $73.5M in Q4 2022. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SVB Wealth held 55,432 shares of AbbVie worth $13.9M as of Q2 2026.
  • SVB Wealth sold 2,857 AbbVie shares in Q2 2026, an estimated $615K.
  • AbbVie made up 0.88% of SVB Wealth's portfolio in Q2 2026, its #25 holding.
  • SVB Wealth first reported a position in AbbVie in Q4 2014 and has held it in 46 quarters since.
  • SVB Wealth's AbbVie position peaked at $73.5M in Q4 2022.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SVB Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.